A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
Anthracyclines, a widely used class of chemotherapeutics, work in several ways to kill rapidly dividing cells, including those found...
This past April, the American Association for Cancer Research welcomed its 2018 class of African Cancer Researchers Travel Award...
As part of ongoing efforts to increase dialogue between cancer patients, survivors, physicians, and researchers, Cancer Today hosts an...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Treatment with checkpoint inhibitors is often billed as gentler than chemotherapy—and it is true that immunotherapy doesn’t come with...
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues...
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Each month, the American Association for Cancer Research (AACR) publishes 10 articles from its eight esteemed scientific journals, showcasing...